4 | SEC Filings Hub

Filing metadata

Accession number: 0001415889-24-020265
Form type: Form 4
Filer: Enliven Therapeutics, Inc.
CIK: CIK 1672619
Filed: Jul 29, 2024
Reporting period: Jul 25, 2024
Description: Insider transaction

Documents

0001415889-24-020265-index.htm

Complete submission

0001415889-24-020265.txt

directory listing

Filed by

Enliven Therapeutics, Inc.